Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suzanne Jaqueth Forrest, M.D.

Concepts (67)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glioma1202233020.330 Why?
Molecular Targeted Therapy2202228240.310 Why?
Medical Oncology1201821180.290 Why?
Neoplasms42022205280.250 Why?
Pediatrics1201835520.220 Why?
Brain Neoplasms1202288050.210 Why?
High-Throughput Nucleotide Sequencing3202236890.190 Why?
Muscular Atrophy, Spinal220122460.180 Why?
Proto-Oncogene Proteins c-ret120202110.170 Why?
Fibrosarcoma120203500.170 Why?
Resource Allocation120203470.170 Why?
Microtubule-Associated Proteins1202211040.150 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma120203740.150 Why?
Oncogenes1202212460.150 Why?
Specimen Handling120206980.140 Why?
Neoplasm, Residual120209860.140 Why?
Mutation12020292910.130 Why?
Antineoplastic Agents12018136260.130 Why?
Child82022744680.120 Why?
Base Sequence12022131790.100 Why?
Soft Tissue Neoplasms1202013560.100 Why?
Child, Preschool52022411980.080 Why?
Infant42022345690.070 Why?
Protein Kinase Inhibitors1202254120.070 Why?
Biomedical Research1202032680.060 Why?
DNA Copy Number Variations1201218940.060 Why?
Gene Expression Regulation, Neoplastic1202085710.060 Why?
Survival of Motor Neuron 2 Protein22012440.060 Why?
Prognosis22020290050.060 Why?
Follow-Up Studies22020393000.050 Why?
Adolescent42022851550.050 Why?
Oncogene Fusion120201100.050 Why?
Tissue Banks120201940.050 Why?
Antineoplastic Combined Chemotherapy Protocols12020112360.050 Why?
Humans920227157770.040 Why?
Clinical Trials, Phase III as Topic120208140.040 Why?
Remission Induction1202023940.030 Why?
Phenotype12012163110.030 Why?
Severity of Illness Index12012159090.030 Why?
Analysis of Variance2201265010.030 Why?
Oncogene Proteins, Fusion1202015940.030 Why?
Motor Activity2201227740.030 Why?
Gas Chromatography-Mass Spectrometry120123770.030 Why?
Fatty Acids, Nonesterified120123790.020 Why?
Male420203503240.020 Why?
Female420203772040.020 Why?
Biopsy1202067360.020 Why?
Chromatography, Liquid120129610.020 Why?
DNA Primers1201229790.020 Why?
Gene Dosage1201212700.020 Why?
Genomics1202253420.020 Why?
Amino Acids1201217110.020 Why?
Tandem Mass Spectrometry1201211190.020 Why?
Survival Rate12020132060.020 Why?
Young Adult22022562260.020 Why?
Case-Control Studies22012217970.020 Why?
Randomized Controlled Trials as Topic1202095960.020 Why?
Prospective Studies22022513150.020 Why?
Metabolomics1201213920.020 Why?
Infant, Newborn12022247980.010 Why?
Cross-Sectional Studies22012234380.010 Why?
Proteomics1201232480.010 Why?
Pilot Projects1201280750.010 Why?
Adult220222122660.010 Why?
Gene Expression Profiling1201295040.010 Why?
Age Factors12012187840.010 Why?
Retrospective Studies12020724430.010 Why?
Forrest's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (67)
Co-Authors (39)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.